OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma
Qiyi Zhang, Wen Ding, Jianshan Mo, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1701-1714
Closed Access | Times Cited: 7
Qiyi Zhang, Wen Ding, Jianshan Mo, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 8, pp. 1701-1714
Closed Access | Times Cited: 7
Showing 7 citing articles:
Nature’s Arsenal: Harnessing the Capacity of Phytochemicals to Enhance Immune Checkpoint Inhibitor Therapy of Cancers: An Especial Attention to Brain Malignancies
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 3
Amir R. Afshari, Mehdi Sanati, Seyed Sajad Ahmadi, et al.
Cancer Letters (2024) Vol. 593, pp. 216955-216955
Closed Access | Times Cited: 3
Targeting the STAT3 pathway with STAT3 degraders
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 3
Zhijie Wang, Xiaotong Liao, Haiqi He, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 811-823
Closed Access | Times Cited: 3
Design, synthesis and biological evaluation of novel naphthoquinothiazole derivatives as potent antitumor agents through inhibiting STAT3
Dongmei Fan, Pingxian Liu, Z.-Q. Li, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107565-107565
Closed Access | Times Cited: 2
Dongmei Fan, Pingxian Liu, Z.-Q. Li, et al.
Bioorganic Chemistry (2024) Vol. 150, pp. 107565-107565
Closed Access | Times Cited: 2
TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma
Dongbo Qiu, Tiantian Wang, Yi Xiong, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Dongbo Qiu, Tiantian Wang, Yi Xiong, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy
Minhyuk Lee, Min-Jae Lee, Youngseo Song, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4737-4737
Open Access | Times Cited: 1
Minhyuk Lee, Min-Jae Lee, Youngseo Song, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4737-4737
Open Access | Times Cited: 1
Advances in hepatocellular carcinoma drug resistance models
Yien Xiang, Junhua Wu, Hanjiao Qin
Frontiers in Medicine (2024) Vol. 11
Open Access
Yien Xiang, Junhua Wu, Hanjiao Qin
Frontiers in Medicine (2024) Vol. 11
Open Access
Acquired resistance to tyrosine kinase targeted therapy: mechanism and tackling strategies
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access
Defa Wu, Qian Sun, Hongjun Tang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101176-101176
Closed Access
